This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Albumin-interleukin-2
Description: Albuleukin is a fusion protein of recombinant human interleukin-2 (rIL-2) and recombinant human serum albumin (rHSA).
Deal Structure: In July 2012, GlaxoSmithKline and Human Genome Sciences entered into a definitive agreement under which GSK will acquire HGS for US$14.25 per share in cash. The acquisition was completed in August 2012.
Pink Sheet Trademark Review
Additional information available to subscribers only: